Comparison of hemostatic agents used in vascular surgery

Expert Opinion on Biological Therapy

Volumn 13, Issue 12, 2013, Pages 1663-1672

  Vyas, Krishna S ^b   Saha, Sibu P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bovine; Fibrin; Fibrinogen; Hemostasis; Sealant; Thrombin; Vascular surgery

Indexed keywords

ADHESIVE AGENT; ALBUMIN; BOVINE SERUM ALBUMIN; CYANOACRYLATE; FIBRIN GLUE; GELATIN; GLUTARALDEHYDE; HEMOSTATIC AGENT; MACROGOL; OXIDIZED REGENERATED CELLULOSE; POLITEF; RECOMBINANT THROMBIN; THROMBIN;

ANTICOAGULATION; ARTERY RECONSTRUCTION; BLEEDING; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONVALESCENCE; HEMOSTASIS; HUMAN; IMMUNOGENICITY; NONHUMAN; OPERATION DURATION; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SURGEON; SURGICAL INFECTION; SURGICAL TECHNIQUE; VASCULAR SURGERY; VEIN RECONSTRUCTION; WOUND HEALING;

BLOOD LOSS, SURGICAL; HEMOSTASIS; HEMOSTATICS; HUMANS; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 84887906149     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.848193     Document Type: Review

References (50)

1. Fast Stats. Inpatient surgery. Centers for Disease Control and Prevention. 2013. Available from: Http://www.cdc. gov/nchs/fastats/insurg.htm [Last accessed 16 September 2013
2. Samudrala S. Topical hemostatic agents in surgery: A surgeon's perspective. AORN J 2008;88:S1-11
3. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112:1506-19
4. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth and stabilization. Cardiovasc Res 2013. [Epub ahead of print
5. Spotnitz WD. Hemostats, sealants, and adhesives: A practical guide for the surgeon. Am Surg 2012;78:1305-21
6. Minato N, Katayama Y, Yunoki J, et al. Hemostatic effectiveness of a new application method for fibrin glue, the "rub-and-spray method", in emergency aortic surgery for acute aortic dissection. Ann Thorac Cardiovasc Surg 2009;15:265-71
7. Go P, Goodman GR, Breun EW, Hunter JG. The argon beam coagulator provides rapid hemostasis of experimental hepatic and splenic hemorrhage in anticoagulated dogs. J Trauma 1991;31:1294-300
8. Woodworth BA, Chandra RK, LeBenger JD, et al. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol 2009;30:49-53
9. Galanakis I, Vasdev N, Soomro N. A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy. Rev Urol 2011;13:131-8
10. Reuthebuch O, Lachat ML, Vogt P, et al. FloSeal: A new hemostyptic agent in peripheral vascular surgery. Vasa 2000;29:204-6
11. Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88:1520-6
12. Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000;69:1376-82
13. Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents. Ann Surg 2010;251:217-28
14. Jackson MR. Fibrin sealants in surgical practice: An overview. Am J Surg 2001;182:1S-7S.
15. Spotnitz WD, Prabhu R. Fibrin sealant: Tissue adhesive -Review and update. J Long Term Med Implants 2005;15:245-70
16. Rousou JA. Use of fibrin sealants in cardiovascular surgery: A systematic review. J Card Surg 2013;28:238-47
17. Cohen DM, Norberto J, Cartabuke R, Ryu G. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999;67:837-8
18. Kaul P. Spontaneous retrograde dissection of ascending aorta from descending thoracic aorta -A case review. Perfusion 2011;26:215-22
19. Lowe J, Luber J, Levitsky S, et al. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: A phase 3, randomized, double-blind clinical study. J Cardiovasc Surg (Torino) 2007;48:323-31
20. Christenson JT, Kalangos A. Autologous fibrin glue reinforced by platelets in surgery of ascending aorta. Thorac Cardiovasc Surg 2004;52:225-9
21. Stark J, de Leval M. Experience with fibrin seal (Tisseel) in operations for congenital heart defects. Ann Thorac Surg 1984;38:411-13
22. Saha S, Muluk S, Schenk W, et al. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of suture hole bleeding in expanded polytetrafluoroethylene grafts. J Vasc Surg 2012;56:134-41
23. Malarkey M, Epstein J. April 2, 2010 Approval Letter -TachoSil. U.S. Food and Drug Administration. Available from: Http://www.fda.gov/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/ FractionatedPlasmaProducts/ucm207486. htm [Last accessed 15 June 2013].
24. Berdajs D, Bürki M, Michelis A, von Segesser LK. Seal properties of TachoSil®: In vitro hemodynamic measurements. Interact CardioVasc Thorac Surg 2010;10:910-13
25. Maisano F, Kjærgard HK, Bauernschmitt R, et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: A randomised controlled trial. Eur J Cardiothorac Surg 2009;36:708-14
26. Pocar M, Passolunghi D, Bregasi A, Donatelli F. TachoSil for postinfarction ventricular free wall rupture. Interact Cardiovasc Thorac Surg 2012;14:866-7
27. Kuschel TJ, Gruszka A, Hermanns-Sachweh B, et al. Prevention of postoperative pericardial adhesions with TachoSil. Ann Thorac Surg 2013;95:183-8
28. Safety and efficacy study of fibrin sealant Grifols evaluated as an adjunct to Hemostasis. Clinical Trials.Gov. Verified March 2013 by Grifols Biologicals, Inc. Available from: Http://www.clinicaltrials. gov/ct2/show/results/NCT00684047? term=Study+to+Evaluate+the+Safety+and +Efficacy+of+Fibrin+Sealant+Grifols+% 28FS+Grifols%29&rank=1 [Last accessed 4 June 2013].
29. Hazelaar S, Dijkstra-Tiekstra MJ, de Korte D, de Wildt-Eggen J. Allogeneic single-donor cryoseal produced from fresh-frozen quarantine apheresis plasma as alternative for multidonor or autologous fibrin sealants. Transfusion 2012;52:517-23
30. Buchta C, Hedrich HC, Macher M, et al. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 2005;26(31):6233-41
31. Medical Devices. CoSeal® Surgical Sealant -P010022. U. S. Food and Drug Administration. Available from: Http:// www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently- ApprovedDevices/ucm083959.htm [Last accessed 14 June 2013].
32. Hill A, Estridge TD, Maroney M, et al. Treatment of suture line bleeding with a novel synthetic surgical sealant in a canine iliac PTFE graft model. J Biomed Mater Res 2001;58:308-12
33. Natour E, Suedkamp M, Dapunt O. Assessment of the effect on blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: A case -control analysis of 102 patients undergoing bentall procedures. J Cardiothorac Surg 2012;7:105
34. Napoleone CP, Oppido G, Angeli E, Gargiulo G. Resternotomy in pediatric cardiac surgery: CoSeal® initial experience. Interact CardioVasc Thorac Surg 2007;6:21-3
35. Nishimura K, Kimura T, Morita A. Watertight dural closure constructed with duraseal® for bypass surgery. Neurol Med Chir (Tokyo) 2012;52:521-4
36. PR Newswire. DuraSeal® sealant receives CE mark for vascular applications. Available from: Http://www.prnewswire. com/news-releases/ durasealr-sealantreceives-ce-mark-for-vascular-applications-55139392.html [Last accessed 17 September] [2013].
37. Adhesives and Sealants.com. DuraSeal® sealant CE mark for thoracic applications. Available from: Http://www.adhesivesandsealants.com/doc/ durasealrsealant-ce-mark-for-thoracic-applic-0001 [Last accessed 17 September 2013].
38. Klijian A. A novel approach to control air leaks in complex lung surgery: A retrospective review. J Cardiothorac Surg 2012;7:49
39. Labenz J, Borsch G. Bleeding and gastric duodenal varicdose veins: Endoscopic embolisation using tissue adhesives. Dtsch Med Wochenschr 1992;117:1274-7
40. Almeida JI, Min RJ, Raabe R, et al. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg 2011;45:631-5
41. Hewitt CW, Marra SW, Kann BR, et al. BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: Efficacy and histopathology. Ann Thorac Surg 2001;71:1609-12
42. Leva C, Bruno PG, Gallorini C, et al. Complete myocardial revascularization and sutureless technique for left ventricular free wall rupture: Clinical and echocardiographic results. Interact Cardiovasc Thorac Surg 2006;5:408-12
43. Passage J, Jalali H, Tam RK, et al. BioGlue surgical adhesive-an appraisal of its indications in cardiac surgery. Ann Thorac Surg 2002;74:432-7
44. Elefteriades JA. How i do it: Utilization of high-pressure sealants in aortic reconstruction. J Cardiothorac Surg 2009;4:27
45. Modi A, Bull R, Tsang G, Kaarne M. Ostial left coronary stenosis following aortic root reconstruction with BioGlue. Interact Cardiovasc Thorac Surg 2011;13:243-5
46. LeMaire SA, Schmittling ZC, Coselli JS, et al. Bioglue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg 2002;73:1500-6
47. Sun JC, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: A systematic review of randomized and observational studies. Eur Heart J 2008;29:2592-600
48. Herman CR, Buth KJ, Kent BA, Hirsch GM. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010;89:397-402
49. Rodgers GM. Immune-mediated coagulopathy associated with topical bovine thrombin: Review of the pediatric literature. J Pediatr Hematol Oncol 2011;33:86-8
50. USF Hemostasis: Usage of HemCon for femoral hemostasis after percutaneous procedures (USF-Hemostasis). Available from: Http://clinicaltrials.gov/show/ NCT00716365 [Last accessed 4 September 2013